Retatrutide

Triple Agonist: GLP-1, GIP, and Glucagon Receptors

Retatrutide represents a pioneering advancement in peptide engineering as a single molecule that acts as an agonist for three distinct metabolic receptors: GLP-1, GIP, and Glucagon (GCG). Early research literature points to its unparalleled potential in modulating energy expenditure, lipolysis, and severe metabolic inflexibility models.

Research Applications

• Tri-receptor metabolic synergistic mechanisms
• Accelerated lipolysis and systemic energy expenditure
• Advanced diabetes and obesity disease state modeling